Stroke remained a leading global killer as incidence gains stalled
Stroke kept its place among the world’s most consequential neurologic emergencies in 2021, despite decades of prevention efforts. The Global Burden of Disease Study 2021 estimated 7.3 million deaths attributable to stroke that year, making it the third most common GBD level 3 cause of death after ischemic heart disease and COVID-19. Stroke also accounted for 160.5 million DALYs, placing it fourth among causes of health loss worldwide. Those numbers reflect more than mortality alone; they capture the long tail of disability that follows many strokes, from motor impairment and aphasia to cognitive decline and dependence on caregivers.
A total of 11.9 million incident strokes and 93.8 million prevalent strokes were estimated in 2021. The burden was not distributed evenly. Rates differed across GBD regions, countries and territories, and Socio-demographic Index quintiles, with particularly concerning patterns in southeast Asia, east Asia, and Oceania. In those settings, incidence, death, prevalence, and DALY rates rose in some populations after years of decline or slower progress. Adults younger than 70 years also carried a growing burden in several locations, a reminder that stroke prevention is no longer a problem reserved for late life.
Ischemic stroke dominated, but hemorrhagic disease still carried substantial weight
The case mix remained heavily weighted toward ischemic stroke, which made up 65.3% of incident events globally in 2021. Intracerebral hemorrhage accounted for 28.8%, and subarachnoid hemorrhage for 5.8%. Those proportions matter at the bedside because each subtype follows a different pathophysiology and demands different prevention strategies. Ischemic stroke tracks closely with atherosclerosis, atrial fibrillation, diabetes, hypertension, and metabolic risk, while intracerebral hemorrhage is strongly linked to uncontrolled blood pressure and vascular fragility. Subarachnoid hemorrhage remains less common, but its abrupt presentation and high early fatality keep it clinically important.
The study also shows how the global stroke problem has matured into a dual challenge. Some countries continue to struggle with the classic vascular drivers of ischemic disease, while others face persistent hemorrhagic burden in the setting of poor blood pressure control, limited access to acute neuroimaging, and inconsistent rehabilitation services. A single prevention playbook cannot fit every health system.
Blood pressure stayed central while metabolic and environmental risks climbed
High systolic blood pressure remained one of the most important contributors to stroke burden, but several other risk factors increased more quickly over time. DALYs attributable to high BMI rose by 88.2%, and those linked to high ambient temperature increased by 72.4%. High fasting plasma glucose rose by 32.1%, and stroke burden tied to a diet high in sugar-sweetened beverages increased by 23.4%. Low physical activity, lead exposure, and a diet low in omega-6 polyunsaturated fatty acids also showed increases in attributable DALYs.
These trends fit the biology of stroke risk. Excess adiposity and dysglycemia promote endothelial dysfunction, inflammation, and a prothrombotic state, all of which can destabilize cerebral circulation. Physical inactivity compounds insulin resistance and hypertension. Lead exposure adds a toxic vascular burden through chronic injury to the cardiovascular system. High ambient temperature introduces a separate stressor, potentially amplifying dehydration, hemodynamic instability, and stroke vulnerability in populations with limited access to cooling, hydration, and medical care.
The increase tied to sugar-sweetened beverages is especially sobering because it reflects a modifiable dietary exposure that operates through weight gain, glycemic load, and downstream vascular injury. Prevention strategies built only around medication will miss a large part of the risk curve.
Stagnation after 2015 points to uneven prevention reach
Global progress slowed after 2015, when the decline in stroke incidence began to stall. In some regions, the trend reversed outright. Southeast Asia, east Asia, and Oceania showed increases in several stroke metrics, and lower-SDI countries were disproportionately affected. That pattern suggests that the gains achieved in earlier decades through antihypertensive treatment, tobacco control, and acute stroke systems did not reach all populations equally, or did not keep pace with rising obesity, diabetes, and environmental exposures.
Age-stratified deterioration in people younger than 70 years raises a separate concern. Stroke in midlife strips working adults of productivity, increases long-term disability, and shifts care burdens onto families for years or decades. For health systems already under strain, that creates a much wider social and economic cost than the death count alone implies.
Surveillance, prevention, and rehabilitation need to move together
The study’s interpretation is direct: stroke burden increased from 1990 to 2021, and several risk factors increased along with it. The implication for clinicians and policymakers is not limited to better acute thrombolysis or thrombectomy programs, though those remain essential. Prevention must stay anchored in blood pressure control, smoking reduction, healthier diets, diabetes management, and physical activity promotion, while also confronting environmental risks such as air pollution, lead exposure, and extreme heat.
Clinical systems also need stronger stroke surveillance. Without reliable incidence and mortality tracking, regions with rising burden can look stable for years while disability accumulates silently. Acute care capacity matters, but so does rehabilitation access, because stroke outcomes are not determined at presentation alone. Survivors need speech therapy, physical therapy, occupational rehabilitation, and long-term secondary prevention if the burden is to decline in a meaningful way.
The scale of the problem leaves little room for fragmented action. Blood pressure control remains the most immediate lever, but the rising contribution of obesity, dysglycemia, diet, inactivity, and environmental exposures shows why stroke prevention now depends on public health infrastructure as much as neurology clinics.